ロード中...
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...
保存先:
| 出版年: | J Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277650/ https://ncbi.nlm.nih.gov/pubmed/30519347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27342 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|